By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neuronetics, Inc. 

One Great Valley Parkway
Suite 2
Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-640-4202 Fax: 610-640-4206


Medical Device

Company News
Neuronetics, Inc. Appoints Christopher Thatcher As President And Chief Executive Officer 12/3/2014 7:35:22 AM
Neuronetics, Inc. Release: Neurostar TMS Therapy® Shows Promise As Effective Once-Monthly Maintenance Therapy In Patients With Major Depressive Disorder 5/6/2014 9:28:26 AM
Neuronetics, Inc. Release: Data Published in CNS Spectrums Indicate Acute Transcranial Magnetic Stimulation (TMS) With NeuroStar TMS Therapy® Improves Quality of Life in Patients with Depression 9/16/2013 11:03:16 AM
Neuronetics, Inc., Announces First Patients Enrolled in Clinical Trial to Evaluate NeuroStar TMS Therapy in Women with Postpartum Depression 7/30/2013 9:20:36 AM
Neuronetics, Inc. Release: New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients With Depression using NeuroStar TMS Therapy System 5/22/2013 9:41:13 AM
Neuronetics, Inc. Release: NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes 3/20/2013 8:51:47 AM
Neuronetics, Inc., Honored with Prestigious Industry Award for the NeuroStar TMS Therapy® System at Phoenix 2012 Conference 10/18/2012 1:00:07 PM
Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy 6/4/2012 8:11:07 AM
Neuronetics, Inc. Release: Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life 5/9/2012 9:59:40 AM
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With Neuronetics, Inc.'s NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting 5/16/2011 7:44:53 AM